Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8022221 Aurora kinase modulators and method of use

Patent 8022221 was granted and assigned to Amgen on September, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

80222210

Patent Inventor Names

Hanh Nho Nguyen0

Bingfan Du0

Brian L. Hodous0

Stephanie D. Geuns-Meyer0

Victor J. Cee0

Vinod F. Patel0

Holly L. Deak0

Karina Romero0

...

Date of Patent

September 20, 2011

Patent Application Number

123784260

Date Filed

February 12, 2009

Patent Citations Received

‌

US Patent 11760728 Tead inhibitors and uses thereof

‌

US Patent 11925651 TEAD inhibitors and uses thereof

Patent Primary Examiner

‌

Venkataraman Balasubramanian

Patent abstract

The present invention relates to chemical compounds having a general formula I

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8022221 Aurora kinase modulators and method of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API